Congenital myasthenic syndrome with glycosylation deficiency (Q92753): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
As síndromes miastênicas congênitas com deficiência de glicosilação incluem defeitos nos seguintes genes: GFPT1, DPAGT1, ALG2 e ALG14. Mutações de perda de função desses genes combinam um padrão de cintura de miastenia autossômica recessiva e agregados tubulares em biópsias musculares.
description / endescription / en
 
Congenital myasthenic syndromes with glycosylation deficiency include GFPT1 defect, DPAGT1 defect, ALG2 defect, and ALG14 defect. Loss-of-function mutations of these genes combine a limb–girdle pattern of autosomal recessively inherited myasthenia and tubular aggregates on muscle biopsies.

Revision as of 07:52, 16 August 2026

Congenital myasthenic syndromes with glycosylation deficiency include GFPT1 defect, DPAGT1 defect, ALG2 defect, and ALG14 defect. Loss-of-function mutations of these genes combine a limb–girdle pattern of autosomal recessively inherited myasthenia and tubular aggregates on muscle biopsies.
Language Label Description Also known as
default for all languages
ID_1600121647
    English
    Congenital myasthenic syndrome with glycosylation deficiency
    Congenital myasthenic syndromes with glycosylation deficiency include GFPT1 defect, DPAGT1 defect, ALG2 defect, and ALG14 defect. Loss-of-function mutations of these genes combine a limb–girdle pattern of autosomal recessively inherited myasthenia and tubular aggregates on muscle biopsies.

      Statements